Last updated on October 2018

Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure

Brief description of study

This is a 24 week, multicenter, randomized, double-blind, parallel group, placebo-controlled study to investigate the effects of saxagliptin and sitagliptin on cardiac dimensions and function in patients with type 2 diabetes (T2DM) mellitus and heart failure (HF).

Clinical Study Identifier: NCT02917031

Contact Investigators or Research Sites near you

Start Over